.INVESTIGATION EMPHASIZE.06 August 2024.
A big randomized regulated test along with cisgender women highlights the challenges of faithfulness to an everyday oral preexposure prophylaxis routine and also shows that twice-yearly treatment of lenacapavir may preserve helpful HIV avoidance degrees over 6 months.